Hypothyroidism after radiotherapy
6.
Chin D., Sklar C., Donahue B., Geneiser N., Allen J.,
Nirenberg A., David R., Kohn B., Oberfield S.
Thyroid dysfunction as a late effect in survivors of
pediatric medulloblastoma/primitive neuroectoder-
mal tumors.
16. Nishiyama K., Tanaka E., Tarui Y., Miyauchi K.,
Okagawa K.
A prospective analysis of subacute thyroid dysfunc-
tion after neck irradiation.
Int. J. Radiat. Oncol. Biol. Phys. 1996, 34: 439-444.
Cancer 1997, 80: 798-804.
17. Williams E.D.
7
8
9
.
.
.
Pretorius H.T., Katikinemi M., Kinsella T.J.
Thyroid nodules after high-dose external radiothe-
rapy.
Biologic effects of radiation on the thyroid.
In: Braverman L.E., Utiger R. (Eds.), Werner and
Ingbar’s The Thyroid, ed. 6.
JAMA 1980, 247: 3217-3220.
J.B. Lippincott Company, New York, 1991, p. 421.
1
8. Rappaport R.
Straub W., Miller M., Sanislow C.
Growth after cranial radiation and chemotherapy for
tumors or leukemia.
Radiation and risk for thyroid cancer: atypical find-
ings of a community thyroid recall program.
Clin. Nucl. Med. 1982, 7: 272-276.
In: Bierich J.R., Cacciari E., Raiti S. (Eds.), Growth
abnormalities.
Raven Press Ltd, New York, 1989, p. 93.
Cohen M.E., Duffner P.K.
Medulloblastoma.
1
9. Corrias A., Altare F., Besenzon L., Ricardi U., Andreo
In: Cohen M.E., Duffner P.K. (Eds.), Brain tumors in
children: principles of diagnosis and treatment,
ed. 2.
M., de Sanctis C.
Difetti accrescitivi e disordini endocrini in pazienti
radiotrattati per tumore cerebrale in età evolutiva.
In: La Causa C., Seminara S., Bindi G. (Eds.), Problema-
tiche attuali sulla diagnosi e terapia delle basse stature.
Scientific Press, Firenze, 1997, p. 249.
Raven Press Ltd, New York, 1994, p. 177.
1
1
1
0. Danjou C.E., Jenkin R.D., Mc Laughlin J., Grimard
L., Gaspar L.E., Dar A.R.
Childhood medulloblastoma in Ontario, 1977-1987:
population-based results.
2
0. Bantel J.P., Lee C.K., Levitte S.
Thyrosine administration during radiation therapy
to the neck does not prevent subsequent thyroid
dysfunction.
Med. Pediatr. Oncol. 1996, 26: 1-9.
1. Constine L.S. Woolf P.D. Cann D. Mick G. McCormick
K., Raubertas R.F., Rubin P.
Int. J. Radiat. Oncol. Biol. Phys. 1985, 11: 1989-2002.
Hypotalamic-pituitary disfunction after radiation for
brain tumors.
N. Engl. J. Med. 1993, 328: 87-94.
2
1. Lee K.O., Persani L., Tan M., Sundram F.X., Beck-
Peccoz P.
Thyrotropin with decreased biological activity, a de-
layed consequence of cranial irradiation for naso-
pharyngeal carcinoma.
2. Littley M.D., Shalet S.M., Beardwell C.G.
Radiation and hypothalamic-pituitary function.
Baillieres Clin. Endocrinol. Metabol. 1990, 4: 147-
J. Endocrinol. Invest. 1995, 18: 800-805.
175.
2
2. Conrad R.A.
13. Shalet S.M.
Late radiation effects in Marshall Islanders exposed
to fallout 28 years ago.
Radiation and pituitary dysfuntion.
N. Engl. J. Med. 1993, 328: 131-133.
In: Bojce J.D., Fraumeni J.F. (Eds.), Radiation carcino-
genesis epidemiology and biological significance.
Raven Press Ltd, New York, 1994, p. 57.
1
4. Ricardi U., Besenzon L., Cordero di Montezemolo
L., Cenni M., Sandri S., Genitori L., Urgesi A.
Low-dose hyperfractionated cranio-spinal radiation
therapy for childhood cerebellar medulloblastoma:
early results of a phase I-II study.
23. Ron E., Modan B., Preston D., Alfandary E., Stovall
M., Boice J.
Thyroid neoplasia following low-dose radiation in
childhood.
Radiat. Res. 1989, 120: 516-531.
Proceedings IX Congress ECCO, Hamburg (Ger-
many) 1997, 911 (Abstract).
1
5. Narayana A., Jeswani S., Paulino A.
The cranial-spinal junction in medulloblastoma: does
it matter?
24. Frankenthaler R.A., Sellin R.V., Cangir A., Goepfert H.
Lymph node metastasis from papillary-follicular thy-
roid carcinoma in young patients.
Int. J. Radia. Oncol. Biol. Phys. 1999, 44: 81-84.
Am. J. Surg. 1990, 180: 341-343.
392